Approval · Notice of Compliance 16175 · 2014
NAPROSYN: Notice of Compliance 16175
Issued October 10, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16175
- Date
- October 10, 2014
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph. removal of 25 mg/ml strength
- Therapeutic class
- Non-steroidal anti-inflammatory drug (nsaid)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROSYN | Not yet assigned | — |